Operational considerations to expedite genomic sequencing component of GISRS surveillance of SARS-CoV-2

Overview

Representative, quality, timely and continuous genetic surveillance of SARS-CoV-2 is critical to the COVID-19 outbreak response. This document provides practical guidance to Global Influenza Surveillance and Response System (GISRS) laboratories and other relevant national laboratories to move beyond virus detection to genomic sequencing of SARS-CoV-2 PCR positive materials obtained from sentinel surveillance of influenza-like illness (ILI), acute respiratory infection (ARI) and severe acute respiratory infection (SARI). It contains considerations on sample selection for sequencing, numbers of viruses to be sequenced, metadata and timeliness for sharing genetic sequence data (GSD) and opportunities for technical support.

WHO Team
Global Influenza Programme WEP, WHO Headquarters (HQ)
Number of pages
10
Reference numbers
WHO Reference Number: WHO/2019-nCoV/genomic_sequencing/GISRS/2021.1
Copyright